Aspire Biopharma Holdings, Inc.
ASBP
$8.87
-$0.38-4.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.05M | -11.76M | -24.48M | -20.54M | -18.90M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 9.60M | 9.60M | 8.02M | 2.02M | -- |
| Total Other Non-Cash Items | -5.85M | -3.50M | 11.00M | 14.10M | 15.70M |
| Change in Net Operating Assets | 111.10K | -548.70K | 533.40K | 897.00K | 299.30K |
| Cash from Operations | -7.19M | -6.21M | -4.92M | -3.52M | -2.91M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 38.30K |
| Total Debt Issued | 9.25M | 9.25M | 10.30M | 9.81M | 3.05M |
| Total Debt Repaid | -7.07M | -6.57M | -3.73M | -3.72M | -221.40K |
| Issuance of Common Stock | 545.50K | 545.50K | 545.50K | 0.00 | 0.00 |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Issuance of Preferred Stock | 17.95M | 8.95M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.53M | -1.45M | -1.19M | -641.70K | 265.80K |
| Cash from Financing | 19.15M | 10.72M | 5.92M | 5.45M | 3.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.96M | 4.51M | 1.00M | 1.93M | 186.60K |